‘Completely new’ cancer treatment strategy will start clinical trials in 2015
By Sharon Kingman
Thursday, April 3, 2014
LONDON – The discovery of an enzyme that is vital to the survival of cancer cells, but which normal cells do not seem to need at all, is pointing to entirely new ways of treating cancer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.